Anna Migdalska‐Richards

1.3k total citations
19 papers, 1.0k citations indexed

About

Anna Migdalska‐Richards is a scholar working on Physiology, Cell Biology and Neurology. According to data from OpenAlex, Anna Migdalska‐Richards has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Cell Biology and 6 papers in Neurology. Recurrent topics in Anna Migdalska‐Richards's work include Lysosomal Storage Disorders Research (8 papers), Cellular transport and secretion (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Anna Migdalska‐Richards is often cited by papers focused on Lysosomal Storage Disorders Research (8 papers), Cellular transport and secretion (6 papers) and Parkinson's Disease Mechanisms and Treatments (6 papers). Anna Migdalska‐Richards collaborates with scholars based in United Kingdom, United States and France. Anna Migdalska‐Richards's co-authors include Anthony H.V. Schapira, Erwan Bézard, Joana Magalhães, Matthew E. Gegg, Graham Molineux, TM Dexter, M Szmitkowski, K M Zsebo, Mary K. Doherty and Phillip D. Whitfield and has published in prestigious journals such as Blood, PLoS ONE and Brain.

In The Last Decade

Anna Migdalska‐Richards

19 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Migdalska‐Richards United Kingdom 11 534 492 283 190 160 19 1.0k
Joanne Wuu United States 14 402 0.8× 197 0.4× 189 0.7× 383 2.0× 80 0.5× 20 1.1k
Bitao Bu China 15 220 0.4× 146 0.3× 110 0.4× 318 1.7× 138 0.9× 42 898
Lluı̈sa Vilageliu Spain 27 1.2k 2.2× 194 0.4× 657 2.3× 742 3.9× 334 2.1× 78 1.7k
Franco Ajmar Italy 19 312 0.6× 341 0.7× 63 0.2× 371 2.0× 33 0.2× 46 1.0k
Federico Diez Argentina 11 181 0.3× 332 0.7× 336 1.2× 434 2.3× 50 0.3× 11 875
Paola Merino United States 14 160 0.3× 124 0.3× 85 0.3× 274 1.4× 91 0.6× 23 580
Mathilde Pruvost France 8 141 0.3× 226 0.5× 66 0.2× 175 0.9× 118 0.7× 13 662
Benjamin Liou United States 16 829 1.6× 161 0.3× 526 1.9× 368 1.9× 188 1.2× 31 1.1k
A. Nazlı Başak Türkiye 17 93 0.2× 306 0.6× 103 0.4× 415 2.2× 43 0.3× 56 864
Ulrich Matzner Germany 24 822 1.5× 50 0.1× 334 1.2× 554 2.9× 313 2.0× 42 1.3k

Countries citing papers authored by Anna Migdalska‐Richards

Since Specialization
Citations

This map shows the geographic impact of Anna Migdalska‐Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Migdalska‐Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Migdalska‐Richards more than expected).

Fields of papers citing papers by Anna Migdalska‐Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Migdalska‐Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Migdalska‐Richards. The network helps show where Anna Migdalska‐Richards may publish in the future.

Co-authorship network of co-authors of Anna Migdalska‐Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Migdalska‐Richards. A scholar is included among the top collaborators of Anna Migdalska‐Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Migdalska‐Richards. Anna Migdalska‐Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Migdalska‐Richards, Anna, et al.. (2024). An Overview of Epigenetic Changes in the Parkinson’s Disease Brain. International Journal of Molecular Sciences. 25(11). 6168–6168. 6 indexed citations
2.
Smith, Adam R., David M. Richards, Katie Lunnon, Anthony H.V. Schapira, & Anna Migdalska‐Richards. (2023). DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson’s Individuals with GBA1 Mutations. International Journal of Molecular Sciences. 24(3). 2687–2687. 7 indexed citations
3.
Migdalska‐Richards, Anna, Michał Węgrzynowicz, Ian F. Harrison, et al.. (2020). L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils. PLoS ONE. 15(8). e0238075–e0238075. 24 indexed citations
4.
Migdalska‐Richards, Anna & Jonathan Mill. (2019). Epigenetic studies of schizophrenia: current status and future directions. Current Opinion in Behavioral Sciences. 25. 102–110. 7 indexed citations
5.
Magalhães, Joana, Matthew E. Gegg, Anna Migdalska‐Richards, & Anthony H.V. Schapira. (2018). Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports. 8(1). 1385–1385. 77 indexed citations
6.
Migdalska‐Richards, Anna, Michał Węgrzynowicz, Raffaella Rusconi, et al.. (2017). The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice. Brain. 140(10). 2706–2721. 63 indexed citations
7.
Migdalska‐Richards, Anna, Wai Kin D. Ko, Qin Li, Erwan Bézard, & Anthony H.V. Schapira. (2017). Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate. Synapse. 71(7). 91 indexed citations
8.
Migdalska‐Richards, Anna & Anthony H.V. Schapira. (2016). The relationship between glucocerebrosidase mutations and Parkinson disease. Journal of Neurochemistry. 139(S1). 77–90. 168 indexed citations
9.
Magalhães, Joana, Matthew E. Gegg, Anna Migdalska‐Richards, et al.. (2016). Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease. Human Molecular Genetics. 25(16). 3432–3445. 178 indexed citations
10.
Migdalska‐Richards, Anna, et al.. (2016). Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice. Annals of Neurology. 80(5). 766–775. 151 indexed citations
11.
Migdalska‐Richards, Anna, et al.. (2014). Endothelin-1-Induced Endoplasmic Reticulum Stress in Parkinson's Disease. Pharmacologia. 5(3). 84–90. 2 indexed citations
12.
Migdalska‐Richards, Anna, Louise van der Weyden, Ozama Ismail, et al.. (2012). Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition. PLoS ONE. 7(1). e29681–e29681. 9 indexed citations
13.
Migdalska‐Richards, Anna, Louise van der Weyden, Ozama Ismail, et al.. (2012). Generation of the Sotos syndrome deletion in mice. Mammalian Genome. 23(11-12). 749–757. 13 indexed citations
14.
Migdalska‐Richards, Anna, Louise van der Weyden, Ozama Ismail, et al.. (2012). Correction: Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition. PLoS ONE. 7(3). 2 indexed citations
15.
Molineux, Graham, et al.. (1994). Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood. 83(12). 3491–3499. 3 indexed citations
16.
Molineux, Graham, et al.. (1994). Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood. 83(12). 3491–3499. 41 indexed citations
17.
Molineux, Graham, Anna Migdalska‐Richards, M Szmitkowski, K M Zsebo, & TM Dexter. (1991). The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood. 78(4). 961–966. 146 indexed citations
18.
19.
Stankiewicz, M., et al.. (1989). Complement activation, phagocytosis, tumor growth and parasitic infection after magnesium supplementation in diet of mice.. PubMed. 8(2). 87–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanne Wuu Breakdown of academic impact, for papers by Bitao Bu Breakdown of academic impact, for papers by Lluı̈sa Vilageliu Breakdown of academic impact, for papers by Franco Ajmar Breakdown of academic impact, for papers by Federico Diez Breakdown of academic impact, for papers by Paola Merino Breakdown of academic impact, for papers by Mathilde Pruvost Breakdown of academic impact, for papers by Benjamin Liou Breakdown of academic impact, for papers by A. Nazlı Başak Breakdown of academic impact, for papers by Ulrich Matzner
Rankless by CCL
2026